Amneal Focuses On Complex Generics As Revenues See Double-Digit Growth
Company Also Plans To File 30 ANDAs This Year
After launching several high-value complex generic products in the last six months, Amneal aims to launch eight more complex generics by August 2021 to add “tremendous value” to its generics business.
